Image

Australian Genomics Of Chronic Allograft Dysfunction Study

Recruiting
18 - 75 years of age
Both
Phase N/A

Powered by AI

Overview

The goal of the Australian Genomics of Chronic Allograft Dysfunction (AUSCAD) study is a single centre (Westmead Hospital), prospective, observational study, which enrols patients at time of kidney (or kidney-transplant) transplant and tracks the post transplant course. The AUSCAD study aims to generate new knowledge and improve outcomes following kidney transplantation. The primary aim is to determine whether important outcomes (including chronic rejection and graft loss) are correlated with patterns of allograft reactivity, gene expression and susceptibility profiles.

Eligibility

Inclusion Criteria:

  • Living or deceased donor kidney transplant candidate.
  • Biological sex: any
  • Ages: 18-75 years.
  • Subject must be able to understand and provide informed consent.
  • Deceased donor individuals where Research Consent has been obtained from the person consenting to organ donation at the time of organ retrieval.
  • Identifiable living donors who have received informed consent and have consented to participate in the project.

Exclusion Criteria:

  • Presensitization in living donor recipients prior to transplantation, as determined by site-specific standards, OR positive cross match according to site specific technique in cadaveric donor recipients.
  • Recipients of multiple organ transplants, with the exception of kidney/pancreas transplants.
  • Inability or unwillingness of a participant to give written informed consent or comply with study protocol
  • High risk populations including pregnant women, children less than 18 years and prisoners will not be included in the study.
  • Non English speaking potential participants who do not understand the requirements of the study will not be included.

Study details

Kidney Transplant Rejection, Kidney Transplant; Complications

NCT06314230

Western Sydney Local Health District

17 April 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.